Literature DB >> 25077699

Role of CT in assessing pleural malignancy prior to thoracoscopy.

R J Hallifax1, M Haris2, J P Corcoran1, S Leyakathalikhan2, E Brown3, D Srikantharaja3, A Manuel1, F V Gleeson4, M Munavvar2, N M Rahman1.   

Abstract

The definitive diagnosis of pleural malignancy depends upon histological confirmation by pleural biopsy. CT is reported to have a high sensitivity and specificity for the diagnosis of malignant pleural disease, and is part of the routine diagnostic workup of these patients. The aim of this study was to assess the sensitivity and specificity of CT in detecting pleural malignancy prior to definitive histology obtained via thoracoscopy in a large cohort of patients with suspected malignant pleural disease. Retrospective review of thoracoscopies between January 2008 and January 2013 at two UK tertiary referral centres: Oxford and Preston. The histological results were compared with the CT reported diagnosis before the procedure. CT scan reports were assessed by independent respiratory physicians as to whether the radiologist concluded evidence of malignant pleural disease or benign features only. 211 (57%) of 370 patients included in the analysis had malignant disease: CT scans were reported as 'malignant' in 144, giving a sensitivity of 68% (95% CI 62% to 75%). Of the 159 patients with benign disease, 124 had CT scans reported as benign: specificity 78% (72% to 84%). The positive predictive value of a malignant CT report was 80% (75% to 86%), with a negative predictive value of 65% (58% to 72%). A significant proportion of patients being investigated for malignant disease will have malignancy despite a negative CT report. The use of CT alone in determining which patients should have invasive pleural biopsies should be re-evaluated, and further studies to define the diagnostic pathway are now required. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Imaging/CT MRI etc; Lung Cancer; Mesothelioma; Pleural Disease

Mesh:

Year:  2014        PMID: 25077699     DOI: 10.1136/thoraxjnl-2014-206054

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  23 in total

Review 1.  Evaluation of the patient with pleural effusion.

Authors:  Stéphane Beaudoin; Anne V Gonzalez
Journal:  CMAJ       Date:  2018-03-12       Impact factor: 8.262

Review 2.  Contemporary approach to the patient with malignant pleural effusion complicating lung cancer.

Authors:  Oleg Epelbaum; Najib M Rahman
Journal:  Ann Transl Med       Date:  2019-08

3.  Early and delayed phases of contrast-enhanced CT for evaluating patients with malignant pleural effusion. Results of pairwise comparison by multiple observers.

Authors:  Juan José Arenas-Jiménez; Elena García-Garrigós; Carmen Escudero-Fresneda; Marina Sirera-Matilla; Irene García-Pastor; Alberto Quirce-Vázquez; Mariana Planells-Alduvin
Journal:  Br J Radiol       Date:  2018-06-27       Impact factor: 3.039

4.  Computed tomography of the chest in unilateral pleural effusions: outcome of the British Thoracic Society guideline.

Authors:  Simon Reuter; Dennis Lindgaard; Christian Laursen; Barbara Malene Fischer; Paul Frost Clementsen; Uffe Bodtger
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

5.  Comparison of cytology, chest computed and positron emission tomography findings in malignant pleural effusion from lung cancer.

Authors:  Clement Brun; Pierre Gay; Michele Cottier; Georgia Karpathiou; Arnaud Patoir; Oliviet Tiffet; Fabrice-Guy Barral; Jean-Michel Vergnon; Marios E Froudarakis
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

6.  Current perspective on the diagnosis of malignant pleural effusion.

Authors:  Jun Hyeok Lim; Jeong-Seon Ryu
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

7.  Imaging for malignant pleural effusions-still no routine role of positron emission tomography.

Authors:  David T Arnold; Nick Maskell
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

8.  Imaging phenotype using radiomics to predict dry pleural dissemination in non-small cell lung cancer.

Authors:  Minglei Yang; Yijiu Ren; Yunlang She; Dong Xie; Xiwen Sun; Jingyun Shi; Guofang Zhao; Chang Chen
Journal:  Ann Transl Med       Date:  2019-06

Review 9.  Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group.

Authors:  Samuel G Armato; Kevin G Blyth; Jane J Keating; Sharyn Katz; Selina Tsim; Johan Coolen; Eyjolfur Gudmundsson; Isabelle Opitz; Anna K Nowak
Journal:  Lung Cancer       Date:  2016-09-05       Impact factor: 5.705

10.  Contrast-enhanced ultrasound guided pleural biopsy improves diagnostic confidence for pleural based lesions: a 3-year prospective study.

Authors:  Wenwen Sun; Yiming Zhou; Cong Yang; Zhengwei Dong; ZheMin Zhang; Yin Wang; Lin Fan
Journal:  BMC Pulm Med       Date:  2021-07-12       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.